Preferential accumulation and export of high molecular weight FGF-2 by rat cardiac non-myocytes

Cardiovascular Research

Volumn 89, Issue 1, 2011, Pages 139-147

  Santiago, Jon Jon ^a,b   Ma, Xin ^a,b   McNaughton, Leslie J ^a   Nickel, Barbara E ^a   Bestvater, Brian P ^a   Yu, Liping ^b   Fandrich, Robert R ^a,b   Netticadan, Thomas ^b   Kardami, Elissavet ^a,b  

^a St Boniface Research Centre   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Angiotensin II; Cardiac non myocytes; Caspase 1; High molecular weight FGF 2 secretion; Hypertrophy

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR 1; ANGIOTENSIN RECEPTOR 2; CASPASE INHIBITOR; FIBROBLAST GROWTH FACTOR 2; HIGH MOLECULAR WEIGHT FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 1BETA CONVERTING ENZYME; LOSARTAN; NEUTRALIZING ANTIBODY; TYROSYLVALYLALANYL ASPARTIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; CARDIAC NONMYOCYTE; CELL; CELL CULTURE; CELL SIZE; CELL SURFACE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVATION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; IMMUNOBLOTTING; MONOLAYER CULTURE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN TRANSPORT; RAT; RECEPTOR BLOCKING;

ANGIOTENSIN II; ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CARDIOMEGALY; CASPASE 1; CELL ENLARGEMENT; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; IMMUNITY, INNATE; MOLECULAR WEIGHT; MYOCARDIUM; MYOCYTES, CARDIAC; MYOFIBROBLASTS; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2;

EID: 78650443677     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq261     Document Type: Article

References (44)

1. Frey N, Katus HA, Olson EN, Hill JA. Hypertrophy of the heart: a new therapeutic target? Circulation 2004;109:1580-1589.
2. Porter KE, Turner NA. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther 2009;123:255-278.
3. Manabe I, Shindo T, Nagai R. Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res 2002;91:1103-1113.
4. Pellieux C, Foletti A, Peduto G, Aubert JF, Nussberger J, Beermann F et al. Dilated cardiomyopathy and impaired cardiac hypertrophic response to angiotensin II in mice lacking FGF-2. J Clin Invest 2001;108:1843-1851.
5. Liao S, Bodmer J, Pietras D, Azhar M, Doetschman T, Schultz Jel J. Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and disease. Dev Dyn 2009;238:249-264.
6. Vagner S, Touriol C, Galy B, Audigier S, Gensac MC, Amalric F et al. Translation of CUG- but not AUG-initiated forms of human fibroblast growth factor 2 is activated in transformed and stressed cells. J Cell Biol 1996;135:1391-1402.
7. Sorensen V, Nilsen T, Wiedlocha A. Functional diversity of FGF-2 isoforms by intra-cellular sorting. Bioessays 2006;28:504-514.
8. Yu PJ, Ferrari G, Pirelli L, Galloway AC, Mignatti P, Pintucci G. Thrombin cleaves the high molecular weight forms of basic fibroblast growth factor (FGF-2): a novel mechanism for the control of FGF-2 and thrombin activity. Oncogene 2008;27:2594-2601.
9. Nickel W. Unconventional secretory routes: direct protein export across the plasma membrane of mammalian cells. Traffic 2005;6:607-614. (Pubitemid 40959689)
10. Clarke MS, Caldwell RW, Chiao H, Miyake K, McNeil PL. Contraction-induced cell wounding and release of fibroblast growth factor in heart. Circ Res 1995;76:927-934.
11. Schultz JE, Witt SA, Nieman ML, Reiser PJ, Engle SJ, Zhou M et al. Fibroblast growth factor-2 mediates pressure-induced hypertrophic response. J Clin Invest 1999;104: 709-719.
12. Jiang ZS, Jeyaraman M, Wen GB, Fandrich RR, Dixon IM, Cattini PA et al. High- but not low-molecular weight FGF-2 causes cardiac hypertrophy in vivo; possible involvement of cardiotrophin-1. J Mol Cell Cardiol 2007;42:222-233.
13. Sugden PH. Signaling pathways activated by vasoactive peptides in the cardiac myocyte and their role in myocardial pathologies. J Card Fail 2002;8:S359-S369.
14. Zimmer HG. Catecholamine-induced cardiac hypertrophy: significance of proto-oncogene expression. J Mol Med 1997;75:849-859.
15. Doble BW, Chen Y, Bosc DG, Litchfield DW, Kardami E. Fibroblast growth factor-2 decreases metabolic coupling and stimulates phosphorylation as well as masking of connexin43 epitopes in cardiac myocytes. Circ Res 1996;79:647-658.
16. Doble BW, Kardami E. Basic fibroblast growth factor stimulates connexin-43 expression and intercellular communication of cardiac fibroblasts. Mol Cell Biochem 1995;143:81-87.
17. Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol 1994;26:809-820.
18. Liu L, Pasumarthi KB, Padua RR, Massaeli H, Fandrich RR, Pierce GN et al. Adult cardiomyocytes express functional high-affinity receptors for basic fibroblast growth factor. Am J Physiol 1995;268:H1927-H1938.
19. Jiang ZS, Srisakuldee W, Soulet F, Bouche G, Kardami E. Non-angiogenic FGF-2 protects the ischemic heart from injury, in the presence or absence of reperfusion. Cardiovasc Res 2004;62:154-166.
20. Sun G, Doble BW, Sun JM, Fandrich RR, Florkiewicz R, Kirshenbaum L et al. CUG-initiated FGF-2 induces chromatin compaction in cultured cardiac myocytes and in vitro. J Cell Physiol 2001;186:457-467.
21. Pasumarthi KB, Kardami E, Cattini PA. High and low molecular weight fibroblast growth factor-2 increase proliferation of neonatal rat cardiac myocytes but have differential effects on binucleation and nuclear morphology. Evidence for both para-crine and intracrine actions of fibroblast growth factor-2. Circ Res 1996;78:126-136.
22. Anderson JE, Liu L, Kardami E. Distinctive patterns of basic fibroblast growth factor (bFGF) distribution in degenerating and regenerating areas of dystrophic (mdx) striated muscles. Dev Biol 1991;147:96-109.
23. Kardami E, Murphy LJ, Liu L, Padua RR, Fandrich RR. Characterization of two preparations of antibodies to basic fibroblast growth factor which exhibit distinct patterns of immunolocalization. Growth Factors 1990;4:69-80.
24. Khalil N, Xu YD, O'Connor R, Duronio V. Proliferation of pulmonary interstitial fibroblasts is mediated by transforming growth factor-beta1-induced release of extracellular fibroblast growth factor-2 and phosphorylation of p38 MAPK and JNK. J Biol Chem 2005;280:43000-43009.
25. Kim HD. Expression of intermediate filament desmin and vimentin in the human fetal heart. Anat Rec 1996;246:271-278.
26. Keller M, Ruegg A, Werner S, Beer HD. Active caspase-1 is a regulator of unconventional protein secretion. Cell 2008;132:818-831.
27. Skaletz-Rorowski A, Pinkernell K, Sindermann JR, Schriever C, Muller JG, Eschert H et al. Angiotensin AT1 receptor upregulates expression of basic fibroblast growth factor, basic fibroblast growth factor receptor and coreceptor in human coronary smooth muscle cells. Basic Res Cardiol 2004;99:272-278.
28. Peng H, Moffett J, Myers J, Fang X, Stachowiak EK, Maher P et al. Novel nuclear signaling pathway mediates activation of fibroblast growth factor-2 gene by type 1 and type 2 angiotensin II receptors. Mol Biol Cell 2001;12:449-462.
29. Jaffre F, Callebert J, Sarre A, Etienne N, Nebigil CG, Launay JM et al. Involvement of the serotonin 5-HT2B receptor in cardiac hypertrophy linked to sympathetic stimulation: control of interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha cytokine production by ventricular fibroblasts. Circulation 2004;110:969-974.
30. Touyz RM, Berry C. Recent advances in angiotensin II signaling. Braz J Med Biol Res 2002;35:1001-1015.
31. Kornacker M, Roth A, Christensen O, Kratzschmar J, Wensing G. Quantification of vascular endothelial growth factor, interleukin-8, and basic fibroblast growth factor in plasma of cancer patients and healthy volunteers-comparison of ELISA and microsphere-based multiplexed immunoassay. Clin Chem Lab Med 2008;46: 1256-1264.
32. Fujita M, Ikemoto M, Kishishita M, Otani H, Nohara R, Tanaka T et al. Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina. Circulation 1996;94:610-613.
33. Gospodarowicz D, Baird A, Cheng J, Lui GM, Esch F, Bohlen P. Isolation of fibroblast growth factor from bovine adrenal gland: physicochemical and biological characterization. Endocrinology 1986;118:82-90. (Pubitemid 16186416)
34. Jaffre F, Bonnin P, Callebert J, Debbabi H, Setola V, Doly S et al. Serotonin and angio-tensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy. Circ Res 2009;104:113-123.
35. Tholozan FM, Gribbon C, Li Z, Goldberg MW, Prescott AR, McKie N et al. FGF-2 release from the lens capsule by MMP-2 maintains lens epithelial cell viability. Mol Biol Cell 2007;18:4222-4231.
36. Clarke MS, Feeback DL. Mechanical load induces sarcoplasmic wounding and FGF release in differentiated human skeletal muscle cultures. FASEB J 1996;10: 502-509.
37. Nickel W, Rabouille C. Mechanisms of regulated unconventional protein secretion. Nat Rev Mol Cell Biol 2009;10:148-155.
38. Dinarello CA. The IL-1 family and inflammatory diseases. Clin Exp Rheumatol 2002;20: S1-S13.
39. Merkle S, Frantz S, Schon MP, Bauersachs J, Buitrago M, Frost RJ et al. A role for caspase-1 in heart failure. Circ Res 2007;100:645-653.
40. Jimenez SK, Sheikh F, Jin Y, Detillieux KA, Dhaliwal J, Kardami E et al. Transcriptional regulation of FGF-2 gene expression in cardiac myocytes. Cardiovasc Res 2004;62: 548-557.
41. Ahmadie R, Santiago JJ, Walker J, Fang T, Le K, Zhao Z et al. A high-lipid diet potentiates left ventricular dysfunction in nitric oxide synthase 3-deficient mice after chronic pressure overload. J Nutr 2010;140:1438-1444.
42. Santiago JJ, Dangerfield AL, Rattan SG, Bathe KL, Cunnington RH, Raizman JE et al. Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts. Dev Dyn 2010;239:1573-1584.
43. Calabro P, Limongelli G, Riegler L, Maddaloni V, Palmieri R, Golia E et al. Novel insights into the role of cardiotrophin-1 in cardiovascular diseases. J Mol Cell Cardiol 2009;46:142-148.
44. Ding L, Donate F, Parry GC, Guan X, Maher P, Levin EG. Inhibition of cell migration and angiogenesis by the amino-terminal fragment of 24 kD basic fibroblast growth factor. J Biol Chem 2002;277:31056-31061.